(redirected from Meloxicam)
Also found in: Dictionary, Medical, Wikipedia.
Related to Meloxicam: cyclobenzaprine
METACAMMeloxicam (medication for dogs)
References in periodicals archive ?
Results: The half-life, maximum concentration, and time to maximum concentration of meloxicam in plasma samples were 2.
Meloxicam and the metabolites were extracted from biological fluids using dichloromethane and the percent recovery for meloxicam, 5-hydroxy meloxicam and 5-carboxy meloxicam were 98.
Meloxicam is an effective analgesic that is selective for cyclooxygenase-2 with well-established efficacy and safety, and, when administered preemptively, promotes better analgesia than buprenorphine (GASSEL et al.
The dogs were treated with cleaning of ear canals with 2% Boric acid and 2% Acetic acid solution, Meloxicam (Melonex (a)) @ 0.
Finally, this patient was treated by oral meloxicam and thalidomide along with yearly infusion of zoledronate.
The medication, Vivlodex, is made using a proprietary technology for producing submicron-size particles of meloxicam that are 10 times smaller than their traditional size, decreasing dissolution time.
NASDAQ: REPH) has closed its acquisition of assets from Alkermes plc and its affiliates including worldwide rights to the IV/IM meloxicam pain drug and a contract manufacturing facility, royalty and formulation business, the company said.
The drugs evaluated by researchers were COX-2 inhibitors, which include celecoxib, rofecoxib, diclofenac, meloxicam, and etodolac, among others.
The NSAID used was Melacam (Medi-vet) which contains Meloxicam 20 mg per ml.
Meloxicam, a selective NSAIDS, has been used as the standard treatment for osteoarticular pain canines (5) but it has been determined that continued use of this drug provokes digestive alterations and hepatic and renal insufficiencies (6-8) in canines.
A study at North Carolina State College of Veterinary Medicine, published in the Journal of Veterinary Internal Medicine, put science to work to investigate the caregiver placebo effect in a clinical trial of meloxicam, a nonsteroidal anti-inflammatory drug commonly used to relieve pain in cats with degenerative joint disease.
10) Diclofenac, celecoxib and meloxicam preferentially inhibit COX-2, while naproxen and ibuprofen preferential inhibit COX-1.